
Global edentity is a biometric technology company developing virtually impenetrable, multi-modal secure identification products to make the world smarter and safer. Their flagship product, U.I.D., combines patented vein-matching and bone-scanning technology with AI to provide dual proof-of-life authentication for governments, corporations, and healthcare providers. The technology works on any body part and can be integrated into small electronic devices like phones, IoT sensors, glasses, or smartwatches. The company targets government agencies, healthcare providers, and enterprises seeking enhanced security for borders, access control, and identity verification. Global edentity holds multiple U.S. patents for their biometric innovations and has received industry recognition such as the 2019 Red Herring Top 100 North America Award. Their business model includes licensing and partnerships with government and corporate clients, aiming to replace legacy identification methods with more secure, faster, and smarter biometric authentication solutions.

Global edentity is a biometric technology company developing virtually impenetrable, multi-modal secure identification products to make the world smarter and safer. Their flagship product, U.I.D., combines patented vein-matching and bone-scanning technology with AI to provide dual proof-of-life authentication for governments, corporations, and healthcare providers. The technology works on any body part and can be integrated into small electronic devices like phones, IoT sensors, glasses, or smartwatches. The company targets government agencies, healthcare providers, and enterprises seeking enhanced security for borders, access control, and identity verification. Global edentity holds multiple U.S. patents for their biometric innovations and has received industry recognition such as the 2019 Red Herring Top 100 North America Award. Their business model includes licensing and partnerships with government and corporate clients, aiming to replace legacy identification methods with more secure, faster, and smarter biometric authentication solutions.
Founded: 2017
Headquarters: Wilmington, Delaware, United States
Product: U.I.D. multimodal biometric authentication (vein/vascular, bone-surface, proof-of-life)
Customers / Targets: Governments, healthcare providers, enterprises
Funding: Seed (Nov 2018), lead: Founders Capital
Patents: Multiple issued U.S. patents
Biometric identity verification and health-detection for security-critical environments.
2017
Biotechnology
Seed round disclosed Nov 2018; some sources list total funding as obfuscated.